Herpes Simplex Virus Mediated Gene Transfer to Neurons

Concepts in Gene Therapy

Volumn , Issue , 2020, Pages 43-59

  Goins, W F ^a,b   Oligino, T ^a,b   Krisky, D ^a,b   Marconi, P ^a,b   Poliani, P L ^a,b   Ramakrishnan, R ^a,b   Fink, D J ^a,b   Glorioso, Joseph C ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004533089     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1515/9783110808636-004     Document Type: Chapter

References (76)

1. Ramakrishnan, R., Krisky, D., Marconi, P., Poliani, P. L., Laquerre, S., Schmidt, M., Fink, D. J., and Glorioso, J. C. (1996b). HSV immediate early proteins participate in promoter silencing during the establishment of latency. Science, (submitted).
2. Roizman, B. and Sears, A. (1996). Herpes simplex viruses and their replication. In: Fields Virology, 2, B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, M. S. Hirsch, J. L. Melnick, T. P. Monath, and Roizman, B.(eds.), (Philadelphia, PA: Lippincott-Raven), pp. 2231-2295.
3. Batterson, W. and Roizman, B. (1983). Characterization of the herpes simplex virion-associated factor responsible for the induction of alpha-genes. J. Virol. 46, 371-377.
4. Campbell, M. E. M., Palfeyman, J. W., and Perston, C. M. (1984). Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription. J. Mol. Biol. 180, 1-19.
5. Kristie, T. and Roizman, B. (1986). DNA-binding site of major regulatory protein alpha 4 specifically associated with the promoter-regulatory domains of alpha genes of herpes simplex virus type 1. Proc. Natl. Acad. Sci. USA 83, 4700-4704.
6. Werstuck, G. and Capone, J. (1993). An unusual cellular factor potentiates protein-DNA complex assembly Oct-1 and Vmw65. J. Biol. Chem. 268, 1272-1278.
7. Wilson, A., LaMarco, K., Peterson, M., and Herr, W. (1993). The VP16 accessory protein HCF is a family of polypeptides processed from a large precursor protein. Cell 74, 115-125.
8. Kwong, A. D., Kruper, J. A., and Frenkel, N. (1988). Herpes simplex virus virion host shutoff function. J. Virol. 62, 912-921.
9. Oroskar, A. and Read, G. (1989). Control of mRNA stability by the virion host shutoff function of herpes simplex virus. J. Virol. 63, 1897-1906.
10. Read, G. S. and Frenkel, N. (1983). Herpes simplex virus mutants defective in the virion-associated shutoff of host polypeptide synthesis and exhibiting abnormal synthesis of a (immediate early) viral polypeptides. J. Virol. 46, 498-512.
11. Newcomb, W. and Brown, J. (1994). Induced extrusion of DNA from the capsid of herpes simplex virus type 1. J. Virol. 68, 443-440.
12. Spear, P. (1993). Membrane fusion induced by herpes simplex virus. In: Viral Fusion Mechanisms, J. Bentz (ed.) (Boca Raton: CRC Press), pp. 201-232.
13. Honess, R. and Roizman, B. (1974). Regulation of herpes simplex virus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14, 8-19.
14. Stevens, J. G. (1989). Human herpesviruses: a consideration of the latent state. Microbiol. Rev. 53, 318-332.
15. Leiden, J., Frenkel, N., and Rapp, F. (1980). Identification of the herpes simplex virus DNA sequences present in six herpes simplex virus thymidine kinase-transformed mouse cell lines. J. Virol. 33, 272-85.
16. DeLuca, N. A., McCarthy, A. M., and Schaffer, P. A. (1985a). Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J. Virol. 56, 558-570.
17. Paterson, T. and Everett, R. D. (1990). A prominent serine-rich region in Vmwl75, the major regulatory of herpes simplex virus type 1, is not essential for virus growth in tissue culture. J. Gen. Virol. 71, 1775-1783.
18. Johnson, P., Miyanohara, A., Levine, F., Cahill, T., and Friedmann, T. (1992). Cytotoxicity of a replication-defective mutant herpes simplex virus type 1. J. Virol. 66, 2952-2965.
19. Desai, P., Ramakrishnan, R., Lin, Z. W., Ozak, B., Glorioso, J. C., and Levine, M. (1993). The RR1 gene of herpes simplex virus type 1 is uniquely transactivated by ICPO during infection. J. Virol. 67, 6125-6135.
20. Dixon, R. A. F. and Schaffer, P. A. (1980). Fine-structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP175. J. Virol. 36, 189-203.
21. Johnson, P., Wang, M., and Friedman, T. (1994). Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the viron host shutoff function. J. Virol. 68, 6347-6362.
22. Krisky, D., Marconi, P., Oligino, T., Ramakrishnan, R., Fink, D. J., and Glorioso, J. C. (1996b). Herpes simplex virus multiple immediate early gene deletion mutants display reduced toxicity in vitro, (submitted).
23. Marconi, P., Krisky, D., Oligino, T., Poliani, P. L., Ramakrishnan, R., Goins, W. F., Fink, D. J., and Glorioso, J. C. (1996). Replication-defective HSV vectors for gene transfer in vivo. Proc. Natl. Acad. Sci. USA 93, 11319-11320.
24. Samaniego, L., Webb, A., and DeLuca, N. (1995). Functional interaction between herpes simplex virus immediate-early proteins during infection, gene expression as a consequence of ICP27 and different domains of ICP4. J. Virol. 69, 5705-5715.
25. Wu, N., Watkins, S. C., Schaffer, P. A., DeLuca, N. A. (1996). Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in immediate-early genes encoding ICP4, ICP27, and ICP22. J. Virol. 70, 6358-6368.
26. Page, B., Page, M., and Noel, C. (1993). A new fluorometric assay for cytotoxicity measurements in vitro. Int. J. Oncology 3, 473-476.
27. Devi-Rao, G. B., Goddart, S. A., Hecht, L. M., Rochford, R., Rice, M. K., and Wagner, E. K. (1991). Relationship between polyadenylated and nonpolyadenylated, HSV type 1 latency-associated transcripts. J. Gen. Virol. 65, 2179-2190.
28. Spivack, J. and Fraser, N. (1988). Expression of herpes simplex virus type 1 latency-associated transcripts in trigeminal ganglia of mice during acture infection and reactivation of latent infection. J. Virol. 62, 1479-1485.
29. Stevens, J. G., Wagner, E. K., Devi-Rao, G. B., Cook, M. L., and Feldman, L. T. (1987). RNA complementary to a herpesviruses a gene mRNA is prominent in latently infected neurons. Science 255, 1056-1059.
30. Wagner, E. K., Flanagan, W. M., Devi-Rao, G. B., Zhang, Y. F., Hill, J. M., Anderson, K. P., and Stevens, J. G. (1988b). The herpes simplex virus latency-associated transcript is spliced during the latent phase of infection. J. Virol. 62, 4577-4585.
31. Farrell, M. J., Dobson, A. T., Feldman, L. T. (1991). Herpes simplex virus latency-associated transcript is a stable intron. Proc. Natl. Acad. Sci. USA 88, 790-794.
32. Wu, T.-T., Su, Y.-H., Block, T. M., and Taylor, J. M. (1996). Evidence that two latency-associated transcripts of herpes simplex virus type 1 are non-linear. J. Virol. 70, 5962-5967.
33. Bloom, D., Hill, J., Devi-Rao, G., Wagner, E., Feldman, L., and Stevens, J. (1996). A 348-base-pair region in the latency-associated transcript facilitates hereps simplex virus type 1 reactivation. J. Virol 70, 2449-2459.
34. Leib, D. A., Nadeau, K. C., Rundle, S. A., Schaffer, P. A. (1991). Promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: role of the latency-associated transcripts and cAMP in reactivation of viral latency. Proc. Natl. Acad. Sci. USA 88, 48-52.
35. Sawtell, N. M. and Thompson, R. L. (1992). Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactviation from latency. J. Virol. 66, 2157-2169.
36. Chen, X., Schmidt, M. C., Goins, W. F., and Glorioso, J. C. (1995). Two herpes simplex virus type-1 latency active promoters differ in their contribution to latency-associated transcript expression during lytic and latent infection. J. Virol. 69, 7899-7908.
37. Dobson, A. T., Sederati, F., Devi-Rao, G., Flanagan, W. M., Farrell, M. J., Stevens, J. G., Wagner, E. K., and Feldman, L. T. (1989). Identification of the latency-associated transcript promoter by expression of rabbit β-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus. J. Virol. 63, 3844-3851.
38. French, S., Goins, W., Montesanti, D., Kinniburgh, A., Schmidt, M., and Glorioso, J. (1996b). In vitro studies of the TATA-less latency active promoter (LAP2) of herpes simplex virus type-1 identify essential promoter elements which form non-B-DNA structures. J. Gen. Virol, (submitted).
39. Goins, W. F., Sternberg, L. R., Croen, K. D., Krause, P. R., Hendricks, R. L., Fink, D. J., Straus, S. E., Levine, M., and Glorioso, J. C. (1994). A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J. Virol. 68, 2239-2252.
40. Soares, M. K., Hwang, D.-Y., Schmidt, M. C., Fink, D. J., and Glorioso, J. C. (1996). Cis-acting elements involved in transcriptional regulation of the herpes simplex virus type-1 latency-associated promoter 1 (LAP1) in vitro and in vivo. J. Virol. 70, 5384-5394.
41. Batchelor, A. H., O’Hare, P. O. (1990). Regulation and cell-type-specific activity of a promoter located upstream of the latency-associated transcript of herpes simplex virus type 1. J. Virol. 64, 3269-3279.
42. Zwaagstra, J. C., Ghiasi, H., Nesburn, A. B., and Wechsler, S. L. (1991). Identification of a major regulatory sequence in the latency-associated transcript (LAT) promoter of herpes simplex virus type 1 (HSV-1). Virology 182, 287-297.
43. Ackland-Berglund, C., Davido, D., and Leib, D.A. (1995). The role of the cAMP-response element and TATA box in expression of the herpes simplex virus type 1 latency-associated transcripts. Virology 210, 141-151.
44. Rader, K. A., Ackland-Berglund, C. E., Miller, J. K., Pepose, J. S., Leib, D. A. (1993). In vivo characterization of site-directed mutations in the promoter of the herpes simplex virus type 1 latencyassociated transcripts.
45. Batchelor, A. H., Wilcox, K. W., and O’Hare, P. (1994). Binding and repression of the latencyassociated promoter of herpes simplex virus by the immediate early 175K protein. J. Gen. Virol. 75, 753-767.
46. Farrell, M. J., Margolis, T. P., Gomes, W. A., and Feldman, L.T. (1994). Effect of the transcription start region of the herpes simplex virus type 1 latency-associated transcript promoter on expression of productively infected neurons in vivo. J. Virol. 68, 5337-5343.
47. Rivera-Gonzalez, R., Imbalzano, A. N., Gu, B., and DeLuca, N.A. (1994). The role of ICP4 repressor activity in the temporal regulation of the IE-3 and latency-associated transcript promoter during herpes simplex virus type-1 infection. Virology 202, 550-564.
48. French, S. W., Schmidt, M. A., and Glorioso, J. C. (1996b). Involvement of a high-mobility-group protein in the transcriptional activity of herpes simplex virus latency-active promoter 2. Mol. Cell. Biol. 16, 5393-5399.
49. Hoffman, E. K., Trusko, S. P., Freeman, N. A., and George, D. L. (1987). Structural and functional characterization of the promoter region of the mouse c-Ki-ras gene. Mol. Cell. Biol. 7, 2592-2596.
50. Johnson, A. C., Jinno, Y., and Merlino, G. T. (1988). Modulation of epidermal growth factor receptor proto-oncogene transcription by a promoter site sensitive to SI nuclease. Mol. Cell. Biol. 8, 4174-4184.
51. Kasai, Y., Chen, H., and Flint, S. J. (1992). Anatomy of an unusual RNA polymerase II promoter containing a downstream TATA element. Mol. Cell. Biol. 12, 2884-2897.
52. Jorcyk, C. L., Watson, D. K., Mavrothalassitis, G. J., Papas, T. S. (1991). The human ETS1 gene: genomic structure, promoter characterization and alternative splicing. Oncogene 6, 523-532.
53. Kim, R. Y., Lietman, T., Piatigorsky, J., and Wistow, G. J. (1991). Structure and expression of the duck a-enolase/t-crystallin-encoding gene. Gene 103, 193-200.
54. Koller, E., Hayman, A. R., Trueb, B. (1991). The promoter of the chicken a2(VI) collagen gene has features characteristic of housekeeping genes and of proto-oncogenes. Nucleic Acids Res. 19, 485-491.
55. Tomarev, S.I., Zinovieva, R. D., and Piatigorsky, J. (1992). Characterization of squid crystallin genes. J. Biol. Chem. 267, 8604-8612.
56. Kolluri, R. and Kinniburgh, A. J. (1991). Full length cDNA sequence encoding a nuclease-sensitive element DNA binding protein. Nucleic Acids Res. 19, 4771.
57. Kolluri, R., Torrey, T. A., and Kinniburgh, A. J. (1992). A CT promoter element binding protein: definition of a double-strand and a novel single-strand DNA binding motif. Nucleic Acids Res. 20, 111-116.
58. Thanos, D. and Maniatis, T. (1992). The high mobility group protein HMG I(Y) is required for NF-kB-dependent virus induction of the human IFN-β gene. Cell 71, 777-789.
59. Falvo, J. V., Thanos, D., and Maniatis, T. (1995). Reversal of intrinsic DNA bends in the IFN-β gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell 83, 1101-1111.
60. Larsen, A. and Weintraub, H. (1982). An altered DNA conformation detected by SI nuclease occurs at specific regions in active chick globin chromatin. Cell 29, 609-622.
61. McKeon, C., Schmidt, A., and Crombrugghe, B. (1984). A sequence conserved in both the chicken and mouse α2(I) collagen promoter contains sites sensitive to SI nuclease. J. Biol. Chem. 259, 6636-6640.
62. Elgin, S.C.R. (1981). DNAase I-hypersensitive sites of chromatin. Cell 27, 413-415.
63. Aimer, A., Rudolph, H., Hinnen, A., and Horz, W. (1986). Removal of positioned nucleosomes from the yeast PH05 promoter upon PH05 induction releases additional upstream activating DNA elements. EMBO J. 5, 2689-2696.
64. Pina, B., Bruggemeier, U., Beato, M. (1990). Nucleosome positioning modulates accessibility of regulatory proteins to the mouse mammary tumor virus promoter. Cell 60, 719-731.
65. Chen, X., Schmidt, M., Goins, W., Fink, D., Hendricks, R., and Glorioso, J. (1996). HSV-1 vectormediated lacZ gene transfer to the nervous system: long-term gene expression using the viral latencyactive promoter, Gene Ther. (submitted).
66. Becker-Andre, M. and Hahlbrook, K. (1989). Absolute mRNA quantitation using the polymerase cahin reaction (PCR): a novel approach by a PCR aided transcript totration assay (PATTY). Nucl. Acids Res. 17, 9437-9446.
67. Gilliland, G. S., Perrin, S., and Bunn, H. F. (1990). Competitive PCR for quantitation of mRNA. In: PCR protocols: a guide to methods and applications., M. A. Innis, J. J. Sninsky and T. J. White (eds.), (New York: Academic Press), pp. 60-69.
68. Ramakrishnan, R., Fink, D. J., Guihua, J., Desai, P., Glorioso, J.C., and Levine, M. (1994b). Competitive quantitative polymerase chain reaction (PCR) analysis of herpes simplex virus type 1 DNA and LAT RNA in latently infected cells of the rat brain. J. Virol. 68, 1864-1870.
69. Ramakrishnan, R., Levine, M., and Fink, D. (1994a). PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant. J. Virol. 68, 7083-7091.
70. Coen, D. M., Kosz-Venchak, M., Jacobson, J. G., Leib, D. A., Bogard, C. L., Schaffer, P. A., Tyler, K. L., and Knipe, D. M. (1989). Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc. Natl. Acad. Sci. USA 86, 4736-4740.
71. Jacobson, J., Leib, D., Goldstein, D., Bogard, C., Schaffer, P., Weller, S., and Coen, D. (1989). A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive, acute, and reactivatible infections for mice and for replication in mouse cells. Virology 173, 276-283.
72. Sadowski, I., Ma, J., Triezenberg, S., Ptashne, M. (1988). GAL4/VP16 is an unusually potent transcriptional activator. Nature 335, 563-564.
73. Carey, M., Leatherwood, J., and Ptashne, M. (1990). A potent GAL4 derivative activates transcription at a distance in vitro. Science 247, 710-712.
74. Chasman, D. I., Leatherwood, M., Carey, M., Ptashne, M., and Komberg, R. D. (1989). Activation of yeast polymerase II transcription by herpesvirus VP16 and GAL4 derivative in vitro. Mol. Cell. Biol. 9, 4746-4749.
75. Oligino, T., Poliani, P. L., Marconi, P., Bender, M. A., Schmidt, M. C., Fink, D. J., and Glorioso, J.C. (1996a) In vivo transgene activation from an HSV-based gene vector by GAL4:VP16. Gene Ther. 3, 892-899.
76. Oligino, T., Poliani, P. L., Wang, Y., Tsai, S.Y., O’Malley, B. W., and Glorioso, J. C. (1996b). Drug inducible transgene expression in brain using a herpes simplex virus vector. J. Virol, (submitted).